Vis enkel innførsel

dc.contributor.authorLynch, Charlotte
dc.contributor.authorHarrison, Samantha
dc.contributor.authorEmery, Jon
dc.contributor.authorClelland, Cathy
dc.contributor.authorDorman, Laurence
dc.contributor.authorCollins, Claire
dc.contributor.authorJohansen, May-Lill
dc.contributor.authorLawrenson, Ross
dc.contributor.authorSurgey, Alun
dc.contributor.authorWeller, David
dc.contributor.authorJarbøl, Dorte Ejg
dc.contributor.authorBalasubramaniam, Kirubakaran
dc.contributor.authorNicholson, Brian
dc.date.accessioned2023-02-02T08:46:04Z
dc.date.available2023-02-02T08:46:04Z
dc.date.issued2022-09-21
dc.description.abstractBackground International variations in cancer outcomes persist and may be influenced by differences in the accessibility and organisation of cancer patient pathways. More evidence is needed to understand to what extent variations in the structure of primary care referral pathways for cancer investigation contribute to differences in the timeliness of diagnoses and cancer outcomes in different countries.<p> <p>Aim To explore the variation in primary care referral pathways for the management of suspected cancer across different countries. Design and setting Descriptive comparative analysis using mixed methods across the International Cancer Benchmarking Partnership (ICBP) countries. <p>Method Schematics of primary care referral pathways were developed across 10 ICBP jurisdictions. The schematics were initially developed using the Aarhus statement (a resource providing greater insight and precision into early cancer diagnosis research) and were further supplemented with expert insights through consulting leading experts in primary care and cancer, existing ICBP data, a focused review of existing evidence on the management of suspected cancer, published primary care cancer guidelines, and evaluations of referral tools and initiatives in primary care. <p>Results Referral pathway schematics for 10 ICBP jurisdictions were presented alongside a descriptive comparison of the organisation of primary care management of suspected cancer. Several key areas of variation across countries were identified: inflexibility of referral pathways, lack of a managed route for non- specific symptoms, primary care practitioner decision- making autonomy, direct access to investigations, and use of emergency routes. <p>Conclusion Analysing the differences in referral processes can prompt further research to better understand the impact of variation on the timeliness of diagnoses and cancer outcomes. Studying these schematics in local contexts may help to identify opportunities to improve care and facilitate discussions on what may constitute best referral practice.en_US
dc.identifier.citationLynch, Harrison, Emery, Clelland, Dorman, Collins, Johansen, Lawrenson, Surgey, Weller, Jarbøl, Balasubramaniam, Nicholson. Variation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnership. British Journal of General Practice 2023; 73 (727): e88-e94.en_US
dc.identifier.cristinIDFRIDAID 2114995
dc.identifier.doi10.3399/BJGP.2022.0110
dc.identifier.issn0960-1643
dc.identifier.issn1478-5242
dc.identifier.urihttps://hdl.handle.net/10037/28468
dc.language.isoengen_US
dc.publisherRoyal College of General Practitionersen_US
dc.relation.journalBritish Journal of General Practice
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by/4.0en_US
dc.rightsAttribution 4.0 International (CC BY 4.0)en_US
dc.titleVariation in suspected cancer referral pathways in primary care: comparative analysis across the International Benchmarking Cancer Partnershipen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution 4.0 International (CC BY 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution 4.0 International (CC BY 4.0)